Entrepreneurship Baidu AI Stock Soars similispharma@gmail.comJuly 1, 20260 EntrepreneurshipBy Arjun MehtaJuly 1, 20268 min read Key Takeaways Significant market developments around Is Baidu (BIDU) One of the AI…
Business News Mark Cuban Warns AI Collapse similispharma@gmail.comJuly 1, 20260 Business NewsBy Rohan DesaiJuly 1, 20267 min read Key Takeaways Mark Cuban warns AI industry could collapse Investors predict AI…
Business News Broadcom Shifts to AI Growth similispharma@gmail.comJune 30, 20260 Business NewsBy Rohan DesaiJune 30, 20269 min read Key Takeaways Broadcom shifts strategy away from acquisitions Goldman Sachs analysts drive…
Business News Baidu AI Chip IPO similispharma@gmail.comJune 30, 20260 Business NewsBy Arjun MehtaJune 30, 20267 min read Key Takeaways Baidu targets $50 billion IPO Kunlunxin leads China's AI sector…
Startups Dell Shares Downgraded Amid Tech Boom similispharma@gmail.comJune 30, 20260 StartupsBy Arjun MehtaJune 30, 20267 min read Key Takeaways Downgrade sparks caution Dell shares surge 200% Cloud computing drives growth…
Startups AI Demand Surges In US similispharma@gmail.comJune 30, 20260 StartupsBy Arjun MehtaJune 30, 20267 min read Key Takeaways Investments surge 50% in AI sector Google struggles to meet AI…
Entrepreneurship NatWest AI Ethics Launch similispharma@gmail.comJune 29, 20260 EntrepreneurshipBy Kavita NairJune 29, 20269 min read Key Takeaways NatWest launches AI ethics accreditation Employees undergo data ethics training AI…
Entrepreneurship AI Investment Gap in US similispharma@gmail.comJune 28, 20260 EntrepreneurshipBy Rohan DesaiJune 28, 20268 min read Key Takeaways Investors pour billions into AI Households spend 0.05% on AI Microsoft…
Startups Steve Eisman Warns On AI Stocks similispharma@gmail.comJune 28, 20260 StartupsBy Kavita NairJune 28, 20267 min read Key Takeaways Investors are overvaluing AI stocks Startups are misusing AI technology Eisman…
Startups OpenAI IPO Delay Hits AI Tokens similispharma@gmail.comJune 28, 20260 StartupsBy Kavita NairJune 28, 20267 min read Key Takeaways Investors scramble to reassess stakes in AI tokens OpenAI's IPO delay…